⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DRMA News
Dermata Therapeutics, Inc. Common Stock
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
accessnewswire.com
DRMA
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
accessnewswire.com
DRMA
DRMAW
Dermata Opens a New Chapter with the Release of Tome Skincare
accessnewswire.com
DRMA
DRMAW
Form 8-K
sec.gov
DRMA
DRMAW
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
accessnewswire.com
DRMA
DRMAW
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
accessnewswire.com
DRMA
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office
accessnewswire.com
DRMA
DRMAW